The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Distinctive patterns of DNA methylation associated with Parkinson disease: Identification of concordant epigenetic changes in brain and peripheral blood leukocytes
Open accessAbstract
Parkinson disease (PD) is a multifactorial neurodegenerative disorder with high incidence in the elderly, where environmental and genetic factors are involved in etiology. In addition, epigenetic mechanisms, including deregulation of DNA methylation have been recently associated to PD. As accurate diagnosis cannot be achieved pre-mortem, identification of early pathological changes is crucial to enable therapeutic interventions before major neuropathological damage occurs. Here we investigated genome-wide DNA methylation in brain and blood samples from PD patients and observed a distinctive pattern of methylation involving many genes previously associated to PD, therefore supporting the role of epigenetic alterations as a molecular mechanism in neurodegeneration. Importantly, we identified concordant methylation alterations in brain and blood, suggesting that blood might hold promise as a surrogate for brain tissue to detect DNA methylation in PD and as a source for biomarker discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Mi, H., Muruganujan, A., & Thomas, P. D. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1118 · Cited by 1,733
High density DNA methylation array with single CpG site resolution
Bibikova, M., Barnes, B., Tsan, C., Ho, V., Klotzle, B., Le, J. M., Delano, D., Zhang, L., Schroth, G. P., Gunderson, K. L., et al. (2011) · Genomics · doi:10.1016/j.ygeno.2011.07.007 · Cited by 1,727 · cited 1×
“Taken in all, comparisons) as DM, a threshold previously suggested to improve detection of DM sites in this array platform with 99% confidence.(27) We identified 317 probes in brain and 476 in blood with increased methylation while 2591 probes in brain and 3421 in blood showed decreased methylation in PD (Table 1).”
Reinius, L. E., Acevedo, N., Joerink, M., Pershagen, G., Dahlén, S.-E., Greco, D., Söderhäll, C., Scheynius, A., & Kere, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041361 · Cited by 1,035
Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer
Baylin, S. B. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.687 · Cited by 929
PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease
Zheng, B., Liao, Z., Locascio, J. J., Lesniak, K. A., Roderick, S. S., Watt, M. L., Eklund, A. C., Zhang-James, Y., Kim, P. D., Hauser, M. A., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001059 · Cited by 857
DNA methylation profiling in the clinic: applications and challenges
Heyn, H., & Esteller, M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3270 · Cited by 746
Neuronal activity modifies the DNA methylation landscape in the adult brain
Guo, J. U., Ma, D. K., Mo, H., Ball, M. P., Jang, M.-H., Bonaguidi, M. A., Balazer, J. A., Eaves, H. L., Xie, B., Ford, E., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2900 · Cited by 669
Aging effects on DNA methylation modules in human brain and blood tissue
Horvath, S., Zhang, Y., Langfelder, P., Kahn, R. S., Boks, M. P., van Eijk, K., van den Berg, L. H., & Ophoff, R. A. (2012) · Genome Biology · doi:10.1186/gb-2012-13-10-r97 · Cited by 645
The Assumptions Underlying the Analysis of Variance
Eisenhart, C. (1947) · Biometrics · doi:10.2307/3001534 · Cited by 634
Davies, M. N., Volta, M., Pidsley, R., Lunnon, K., Dixit, A., Lovestone, S., Coarfa, C., Harris, R. A., Milosavljevic, A., Troakes, C., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-6-r43 · Cited by 630
Decline in genomic DNA methylation through aging in a cohort of elderly subjects
Bollati, V., Schwartz, J., Wright, R., Litonjua, A., Tarantini, L., Suh, H., Sparrow, D., Vokonas, P., & Baccarelli, A. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.12.003 · Cited by 594
Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies
Urdinguio, R. G., Sanchez-Mut, J. V., & Esteller, M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70262-5 · Cited by 582
Do, C. B., Tung, J. Y., Dorfman, E., Kiefer, A. K., Drabant, E. M., Francke, U., Mountain, J. L., Goldman, S. M., Tanner, C. M., Langston, J. W., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002141 · Cited by 515
DNA methylation and memory formation
Day, J. J., & Sweatt, J. D. (2010) · Nature Neuroscience · doi:10.1038/nn.2666 · Cited by 486
Edwards, T. L., Scott, W. K., Almonte, C., Burt, A., Powell, E. H., Beecham, G. W., Wang, L., Züchner, S., Konidari, I., Wang, G., et al. (2010) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2009.00560.x · Cited by 465
Jowaed, A., Schmitt, I., Kaut, O., & Wüllner, U. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.6119-09.2010 · Cited by 434
A Genomic Pathway Approach to a Complex Disease: Axon Guidance and Parkinson Disease
Lesnick, T. G., Papapetropoulos, S., Mash, D. C., Ffrench-Mullen, J., Shehadeh, L., de Andrade, M., Henley, J. R., Rocca, W. A., Ahlskog, J. E., & Maraganore, D. M. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030098 · Cited by 411
A DNA methylation fingerprint of 1628 human samples
Fernandez, A. F., Assenov, Y., Martin-Subero, J. I., Balint, B., Siebert, R., Taniguchi, H., Yamamoto, H., Hidalgo, M., Tan, A.-C., Galm, O., et al. (2012) · Genome Research · doi:10.1101/gr.119867.110 · Cited by 411
Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders.
Takeda, A., Mallory, M. E., Sundsmo, M. P., Honer, W. G., Hansen, L. A., & Masliah, E. (1998) · Europe PMC (PubMed Central) · Cited by 403
Self-citationStenvinkel, P., Karimi, M., Johansson, S., Axelsson, J., Suliman, M., Lindholm, B., Heimbürger, O., Barany, P., Alvestrand, A., Nordfors, L., et al. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01777.x · Cited by 396
Ontology-Based Meta-Analysis of Global Collections of High-Throughput Public Data
Kupershmidt, I., Su, Q. J., Grewal, A., Sundaresh, S., Halperin, I., Flynn, J., Shekar, M., Wang, H., Park, J., Cui, W., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013066 · Cited by 368
Simunovic, F., Yi, M., Wang, Y., Macey, L., Brown, L. T., Krichevsky, A. M., Andersen, S. L., Stephens, R. M., Benes, F. M., & Sonntag, K. C. (2009) · Brain · doi:10.1093/brain/awn323 · Cited by 354
Matsumoto, L., Takuma, H., Tamaoka, A., Kurisaki, H., Date, H., Tsuji, S., & Iwata, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015522 · Cited by 308
α-Synuclein Sequesters Dnmt1 from the Nucleus
Desplats, P., Spencer, B., Coffee, E., Patel, P., Michael, S., Patrick, C., Adame, A., Rockenstein, E., & Masliah, E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.212589 · Cited by 305
Self-citationCell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps
Levy, O. A., Malagelada, C., & Greene, L. A. (2009) · Apoptosis · doi:10.1007/s10495-008-0309-3 · Cited by 287
Naumova, O. Y., Lee, M., Koposov, R., Szyf, M., Dozier, M., & Grigorenko, E. L. (2012) · Development and Psychopathology · doi:10.1017/s0954579411000605 · Cited by 258
Zhang, Y., James, M., Middleton, F. A., & Davis, R. L. (2005) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30195 · Cited by 258
Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson’s disease
Moran, L. B., Duke, D. C., Deprez, M., Dexter, D. T., Pearce, R. K. B., & Graeber, M. B. (2006) · neurogenetics · doi:10.1007/s10048-005-0020-2 · Cited by 242
Power Calculations for General Linear Multivariate Models Including Repeated Measures Applications
Muller, K. E., Lavange, L. M., Ramey, S. L., & Ramey, C. T. (1992) · Journal of the American Statistical Association · doi:10.1080/01621459.1992.10476281 · Cited by 230
The UK Parkinson's Disease Consortium and The Wellcome Trust Case Control Consortium 2, Spencer, C. C. A., Plagnol, V., Strange, A., Gardner, M., Paisan-Ruiz, C., Band, G., Barker, R. A., Bellenguez, C., Bhatia, K., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq469 · Cited by 219
Gene Promoter Methylation in Plasma and Sputum Increases with Lung Cancer Risk
Belinsky, S. A., Klinge, D. M., Dekker, J. D., Smith, M. W., Bocklage, T. J., Gilliland, F. D., Crowell, R. E., Karp, D. D., Stidley, C. A., & Picchi, M. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0625 · Cited by 215
Heterogeneity in White Blood Cells Has Potential to Confound DNA Methylation Measurements
Adalsteinsson, B. T., Gudnason, H., Aspelund, T., Harris, T. B., Launer, L. J., Eiriksdottir, G., Smith, A. V., & Gudnason, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046705 · Cited by 202
Cortical thinning is associated with disease stages and dementia in Parkinson's disease
Zarei, M., Ibarretxe-Bilbao, N., Compta, Y., Hough, M., Junque, C., Bargallo, N., Tolosa, E., & Marti, M. J. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304126 · Cited by 191
Polyamine pathway contributes to the pathogenesis of Parkinson disease
Lewandowski, N. M., Ju, S., Verbitsky, M., Ross, B., Geddie, M. L., Rockenstein, E. M., Adame, A., Muhammad, A., Vonsattel, J. P., Ringe, D., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011751107 · Cited by 161
Self-citationTumor-Specific Methylation in Bronchial Lavage for the Early Detection of Non-Small-Cell Lung Cancer
Kim, H., Kwon, Y. M., Kim, J. S., Lee, H., Park, J., Shim, Y. M., Han, J., Park, J., & Kim, D.-H. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.077 · Cited by 146
Jain, K. K. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-685-6 · Cited by 138
Nakamura, T., Cho, D., & Lipton, S. A. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.06.032 · Cited by 114
He, Q., Chen, H., Bai, E., Luo, Y., Fu, R., He, Y.-S., Jiang, J., & Wang, H. (2010) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2010.05.018 · Cited by 106
Desplats, P., Patel, P., Kosberg, K. A., Mante, M., Patrick, C., Rockenstein, E. M., Fujita, M., Hashimoto, M., & Masliah, E. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-49 · Cited by 88
Self-citationA genome-wide DNA methylation study in colorectal carcinoma
Kibriya, M. G., Raza, M., Jasmine, F., et al. (2011) · BMC Medical Genomics · doi:10.1186/1755-8794-4-50 · Cited by 69
Transcriptional dysregulation in a transgenic model of Parkinson disease
Yacoubian, T. A., Cantuti‐Castelvetri, I., Bouzou, B., Asteris, G., McLean, P. J., Hyman, B. T., & Standaert, D. G. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.11.008 · Cited by 68
Inflammatory Pathways in Parkinson’s Disease; A BNE Microarray Study
Durrenberger, P. F., Grünblatt, E., Fernando, F. S., Monoranu, C. M., Evans, J., Riederer, P., Reynolds, R., & Dexter, D. T. (2012) · Parkinson's Disease · doi:10.1155/2012/214714 · Cited by 63
Cortical Lewy body disease and Parkinson's disease dementia
Burn, D. J. (2006) · Current Opinion in Neurology · doi:10.1097/01.wco.0000247607.34697.a2 · Cited by 60
Miñones-Moyano, E., Friedländer, M. R., Pallarès-Albanell, J., Kagerbauer, B., Porta, S., Escaramís, G., Ferrer, I., Estivill, X., & Martí, E. (2013) · RNA Biology · doi:10.4161/rna.24813 · Cited by 56
Prefrontal Cortical Dysfunction After Overexpression of Histone Deacetylase 1
Jakovcevski, M., Bharadwaj, R. A., Straubhaar, J., Gao, G., Gavin, D. P., Jakovčevski, I., Mitchell, A., & Akbarian, S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.020 · Cited by 49
Biomarkers for Parkinson's disease
Graeber, M. B. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2008.12.017 · Cited by 30
Brain volumetry in Parkinson's disease with and without dementia: where are the differences?
Lee, S.-H., Kim, S. S., Tae, W., Lee, S., Lee, K. U., & Jhoo, J. (2013) · Acta Radiologica · doi:10.1177/0284185113476029 · Cited by 23
Cited by
Parkinson’s Disease: From Pathogenesis to Pharmacogenomics
Cacabelos, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030551 · Cited by 555
CpG and non-CpG methylation in epigenetic gene regulation and brain function
Jang, H., Shin, W., Lee, J., & Do, J. (2017) · Genes · doi:10.3390/genes8060148 · Cited by 427
Palma-Gudiel, H., Córdova-Palomera, A., Leza, J. C., & Fañanás, L. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.016 · Cited by 347
Progress in unraveling the genetic etiology of Parkinson disease in a genomic era
Verstraeten, A., Theuns, J., & Van Broeckhoven, C. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.01.004 · Cited by 226
Martín-Blanco, A., Ferrer, M., Soler, J., Salazar, J., Vega, D., Andión, O., Sanchez-Mora, C., Arranz, M. J., Ribases, M., Feliu-Soler, A., et al. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.06.011 · Cited by 138
Metadata
- Authors
- Masliah, E., Dumaop, W., Galasko, D., & Desplats, P.
- Venue
- Epigenetics
- Publisher
- Informa UK Limited
- Published
- 2013-10
- Volume
- 8
- Issue
- 10
- Pages
- 1030-1038
- ISSN
- 1559-2294 (ISSN-L)
- 1559-2308
- OpenAlex
- W1974473791
- Cited by
- 319
- References
- 51
- FWCI
- 15.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.